Clinical trial
Persistence of Biological Treatment and Inhibitors of Jak Kinases in Habitual Clinical Practice in Patients With Rheumatoid Arthritis. Influence of the Comorbidities.
NCT05062421 is registered in ClinicalTrials.gov with Fundación Pública Andaluza para la gestión de la Investigación en Sevilla as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Persistence of Biological Treatment and Inhibitors of Jak Kinases in Habitual Clinical Practice in Patients With Rheumatoid Arthritis. Influence of the Comorbidities.
- Lead sponsor
- Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- April 1, 2021
- Completion date
- December 31, 2026
- Enrollment
- 540 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.